Literature DB >> 4113222

Acute renal failure after rifampicin.

D Kleinknecht, J C Homberg, G Decroix.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4113222     DOI: 10.1016/s0140-6736(72)90959-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance.

Authors:  R Kropp; M Krüpe; H Jungbluth
Journal:  Pneumonologie       Date:  1976-04-09

2.  Sensitivity to rifampicin: incidence, mechanism, and prevention.

Authors:  J C Pujet; J C Homberg; G Decroix
Journal:  Br Med J       Date:  1974-05-25

3.  Hepatorenal failure with self-initiated intermittent rifampicin therapy.

Authors:  D L Rothwell; D E Richmond
Journal:  Br Med J       Date:  1974-06-01

4.  Acute renal failure and rifampicin: danger of unsuspected intermittent dosage.

Authors:  C T Flynn; D J Rainford; E Hope
Journal:  Br Med J       Date:  1974-06-01

5.  Idiopathic acute interstitial nephritis.

Authors:  M L Graber; M G Cogan; D G Connor
Journal:  West J Med       Date:  1978-07

6.  Rifampicin induced light chain proteinuria and renal failure.

Authors:  R J Winter; R A Banks; C M Collins; B I Hoffbrand
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

7.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

8.  Acute diffuse interstitial nephritis related to chemotherapy of tuberculosis.

Authors:  W J Stone; J A Waldron; J H Dixon; R K primm; R G Horn
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

9.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.